Pursuant to Regulation 24A of the SEBI (LODR) Regulations, 2015, read with applicable circulars issued by the SEBI, BSE and NSE, from time to time, please find enclosed herewith the Annual ....
INNOVACAP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Innova Captab Limited has submitted its Annual Secretarial Compliance Report for FY2026, prepared by Practicing Company Secretary Jaspreet Singh Dhawan of Jaspreet Dhawan & Associates. The report examines compliance across multiple SEBI regulations including LODR, ICDR, SAST, PIT, Depositories, and Fraudulent Trade Practices regulations. The company has reported full compliance with all applicable regulations during the review period — no deviations, fines, or penalties were recorded. All 13 compliance checkpoints reviewed returned a 'Yes' status, covering areas such as secretarial standards, policy adoption, website disclosures, director disqualification checks, related party transactions, insider trading norms, and statutory auditor requirements. The company has two material subsidiaries: Univentis Medicare Limited and Sharon Bio-Medicine Limited.
Clean compliance report with zero deviations is a positive signal for investors, indicating strong internal controls and regulatory adherence. No adverse actions from SEBI or stock exchanges during the review period.